Showing 1 - 11 results of 11 for search 'Robert J. Glynn', query time: 0.05s Refine Results
  1. 1
    Evaluation of Risk Prediction with Hierarchical Data: Dependency Adjusted Confidence Intervals for the AUC

    Evaluation of Risk Prediction with Hierarchical Data: Dependency Adjusted Confidence Intervals for the AUC by Camden Bay, Robert J Glynn, Johanna M Seddon, Mei-Ling Ting Lee, Bernard Rosner

    Published 2023-04-01
    Get full text
    Article
  2. 2
    Designing and conducting adaptive trials to evaluate interventions in health services and implementation research: practical considerations

    Designing and conducting adaptive trials to evaluate interventions in health services and implementation research: practical considerations by Robert J Glynn, Niteesh K Choudhry, Julie C Lauffenburger, Lorenzo Trippa, Massimiliano Russo, Steffen Ventz

    Published 2022-12-01
    Get full text
    Article
  3. 3
    Exploring patient experiences coping with using multiple medications: a qualitative interview study

    Exploring patient experiences coping with using multiple medications: a qualitative interview study by Daniel H Solomon, Robert J Glynn, Niteesh K Choudhry, Julie C Lauffenburger, Nancy Haff, Marie E McDonnell, Elliott M Antman

    Published 2021-11-01
    Get full text
    Article
  4. 4
    Investigating the ability to adhere to cardiometabolic medications with different properties: a retrospective cohort study of >500 000 patients in the USA

    Investigating the ability to adhere to cardiometabolic medications with different properties: a retrospective cohort study of >500 000 patients in the USA by Daniel H Solomon, Robert J Glynn, Niteesh K Choudhry, Julie C Lauffenburger, Elliott M Antman, Su Been Lee, Helen Tesfaye, Angela Tong

    Published 2023-11-01
    Get full text
    Article
  5. 5
    Impact of RA treatment strategies on lipids and vascular inflammation in rheumatoid arthritis: a secondary analysis of the TARGET randomized active comparator trial

    Impact of RA treatment strategies on lipids and vascular inflammation in rheumatoid arthritis: a secondary analysis of the TARGET randomized active comparator trial by Katherine P. Liao, Pamela Rist, Jon Giles, Leah Santacroce, Margery A. Connelly, Robert J. Glynn, Paul Ridker, Ahmed Tawakol, Joan Bathon, Daniel H. Solomon

    Published 2024-06-01
    Get full text
    Article
  6. 6
    Frailty and Clinical Outcomes of Ticagrelor Versus Clopidogrel in Older Adults With Acute Myocardial Infarction

    Frailty and Clinical Outcomes of Ticagrelor Versus Clopidogrel in Older Adults With Acute Myocardial Infarction by Darae Ko, Peter T. Evans, Kueiyu Joshua Lin, Ashvin N. Pande, Alexander Cervone, Su Been Lee, Susan Cheng, Theodore Tsacogianis, Robert J. Glynn, Dae Hyun Kim

    Published 2024-08-01
    Get full text
    Article
  7. 7
    Socioeconomic status and incident type 2 diabetes mellitus: data from the Women's Health Study.

    Socioeconomic status and incident type 2 diabetes mellitus: data from the Women's Health Study. by Timothy C Lee, Robert J Glynn, Jessica M Peña, Nina P Paynter, David Conen, Paul M Ridker, Aruna D Pradhan, Julie E Buring, Michelle A Albert

    Published 2011-01-01
    Get full text
    Article
  8. 8
    Correction: Cardiorenal effectiveness of empagliflozin vs. glucagon-like peptide-1 receptor agonists: final-year results from the EMPRISE study

    Correction: Cardiorenal effectiveness of empagliflozin vs. glucagon-like peptide-1 receptor agonists: final-year results from the EMPRISE study by Phyo T. Htoo, Helen Tesfaye, Sebastian Schneeweiss, Deborah J. Wexler, Brendan M. Everett, Robert J. Glynn, Niklas Schmedt, Lisette Koeneman, Anouk Déruaz-Luyet, Julie M. Paik, Elisabetta Patorno

    Published 2024-03-01
    Get full text
    Article
  9. 9
    Cardiorenal effectiveness of empagliflozin vs. glucagon-like peptide-1 receptor agonists: final-year results from the EMPRISE study

    Cardiorenal effectiveness of empagliflozin vs. glucagon-like peptide-1 receptor agonists: final-year results from the EMPRISE study by Phyo T. Htoo, Helen Tesfaye, Sebastian Schneeweiss, Deborah J. Wexler, Brendan M. Everett, Robert J. Glynn, Niklas Schmedt, Lisette Koeneman, Anouk Déruaz-Luyet, Julie M. Paik, Elisabetta Patorno

    Published 2024-02-01
    Get full text
    Article
  10. 10
    Adverse Effects of Low‐Dose Methotrexate in a Randomized Double‐Blind Placebo‐Controlled Trial: Adjudicated Hematologic and Skin Cancer Outcomes in the Cardiovascular Inflammation Reduction Trial

    Adverse Effects of Low‐Dose Methotrexate in a Randomized Double‐Blind Placebo‐Controlled Trial: Adjudicated Hematologic and Skin Cancer Outcomes in the Cardiovascular Inflammation... by Kathleen M.M. Vanni, Nancy Berliner, Nina P. Paynter, Robert J. Glynn, Jean MacFadyen, Joshua Colls, Fengxin Lu, Chang Xu, Paul M. Ridker, Daniel H. Solomon

    Published 2020-12-01
    Get full text
    Article
  11. 11
    Analyzing missingness patterns in real-world data using the SMDI toolkit: application to a linked EHR-claims pharmacoepidemiology study

    Analyzing missingness patterns in real-world data using the SMDI toolkit: application to a linked EHR-claims pharmacoepidemiology study by Sudha R. Raman, Bradley G. Hammill, Pamela A. Shaw, Hana Lee, Sengwee Toh, John G. Connolly, Kimberly J. Dandreo, Vinit Nalawade, Fang Tian, Wei Liu, Jie Li, José J. Hernández-Muñoz, Robert J. Glynn, Rishi J. Desai, Janick Weberpals

    Published 2024-10-01
    Get full text
    Article

Search Tools: